Loading…
Canaloplasty - Efficacy and Safety in an 18-Month Follow Up Period, and Analysis of Outcomes in Primary Open Angle Glaucoma Pigmentary Glaucoma and Pseudoexfoliative Glaucoma
Open-angle glaucoma (OAG), accounting for 90% of all glaucoma cases, is a progressive optic nerve neuropathy. It may lead to irreversible loss of visual field and complete blindness. When conservative treatment becomes insufficient to stop OAG progression, a surgical intervention is considered. Curr...
Saved in:
Published in: | Seminars in ophthalmology 2022-07, Vol.37 (5), p.602-610 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c366t-b70b13c6014373c4092d3164827a3546d95b83dbc0113b7db90b6788d8a482653 |
---|---|
cites | cdi_FETCH-LOGICAL-c366t-b70b13c6014373c4092d3164827a3546d95b83dbc0113b7db90b6788d8a482653 |
container_end_page | 610 |
container_issue | 5 |
container_start_page | 602 |
container_title | Seminars in ophthalmology |
container_volume | 37 |
creator | Łazicka - Gałecka, Monika Kamińska, Anna Gałecki, Tomasz Guszkowska, Maria Dziedziak, Jacek Szaflik, Jerzy Szaflik, Jacek P. |
description | Open-angle glaucoma (OAG), accounting for 90% of all glaucoma cases, is a progressive optic nerve neuropathy. It may lead to irreversible loss of visual field and complete blindness. When conservative treatment becomes insufficient to stop OAG progression, a surgical intervention is considered. Currently, canaloplasty procedure is being introduced instead of conventional trabeculectomy for invasive OAG treatment. The aim of the study is to asses safety and efficacy of canaloplasty.
This prospective study included 67 eyes that received 360° canaloplasty with placement of a tensioning suture. Primary OAG (n = 35), secondary OAG in pseudoexfoliative syndrome (n = 13), and pigmentary glaucoma (n = 19) patients were included. Control check-ups were conducted pre-operatively and in a 18-month follow-up time. Study endpoints involved reduction in IOP values and in the number of glaucoma medications after the intervention.
The intervention led to a significant 38% reduction in IOP value from the preoperative baseline to 18 months after the intervention. The number of medications decreased significantly by 89%. At 18 months postoperative, 79% eyes did not require any glaucoma medications. The incidence of complications after canaloplasty was low, and none of the adverse effects were vision threatening. A surgically-induced astigmatism was the most frequent complication. Pigmentary glaucoma patients were the most beneficial subgroup, with 50% reduction in IOP, the highest success rate, and 98% reduction in the number of medications used.
This study proved that canaloplasty is an efficient and safe procedure in OAG eyes. |
doi_str_mv | 10.1080/08820538.2022.2034897 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2626227665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2626227665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-b70b13c6014373c4092d3164827a3546d95b83dbc0113b7db90b6788d8a482653</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EokPhEUBesiDFP0ns2VGN2lKpaEZqu7Yc_xQjxw520pKX4hlxOtN2hyzZuvd-51xZB4CPGJ1gxNFXxDlBDeUnBBFSLlrzNXsFVpjVddWU0WuwWphqgY7Au5x_IUQwI_QtOKINJg1qyAr83cggfRy8zOMMK3hmrVNSzVAGDa-lNaXrQqkg5tWPGMaf8Dx6Hx_g7QB3Jrmovzyyp8Vmzi7DaOF2GlXsTV6Uu-R6mWa4HUwo0J038MLLqcwl3Lm73oRxGT_3Fq9dNpOO5o-N3snR3b9I3oM3VvpsPhzeY3B7fnaz-V5dbS8uN6dXlaJtO1YdQx2mqkW4poyqGq2JpritOWGSNnWr103Hqe4Uwph2THdr1LWMc81lYdqGHoPPe98hxd-TyaPoXVbGexlMnLIgbTmEtY9os0dVijknY8Ww_7LASCxRiaeoxBKVOERVdJ8OK6auN_pZ9ZRNAb7tARdsTL18iMlrMcrZx2STDMplQf-_4x8deqLc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626227665</pqid></control><display><type>article</type><title>Canaloplasty - Efficacy and Safety in an 18-Month Follow Up Period, and Analysis of Outcomes in Primary Open Angle Glaucoma Pigmentary Glaucoma and Pseudoexfoliative Glaucoma</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Łazicka - Gałecka, Monika ; Kamińska, Anna ; Gałecki, Tomasz ; Guszkowska, Maria ; Dziedziak, Jacek ; Szaflik, Jerzy ; Szaflik, Jacek P.</creator><creatorcontrib>Łazicka - Gałecka, Monika ; Kamińska, Anna ; Gałecki, Tomasz ; Guszkowska, Maria ; Dziedziak, Jacek ; Szaflik, Jerzy ; Szaflik, Jacek P.</creatorcontrib><description>Open-angle glaucoma (OAG), accounting for 90% of all glaucoma cases, is a progressive optic nerve neuropathy. It may lead to irreversible loss of visual field and complete blindness. When conservative treatment becomes insufficient to stop OAG progression, a surgical intervention is considered. Currently, canaloplasty procedure is being introduced instead of conventional trabeculectomy for invasive OAG treatment. The aim of the study is to asses safety and efficacy of canaloplasty.
This prospective study included 67 eyes that received 360° canaloplasty with placement of a tensioning suture. Primary OAG (n = 35), secondary OAG in pseudoexfoliative syndrome (n = 13), and pigmentary glaucoma (n = 19) patients were included. Control check-ups were conducted pre-operatively and in a 18-month follow-up time. Study endpoints involved reduction in IOP values and in the number of glaucoma medications after the intervention.
The intervention led to a significant 38% reduction in IOP value from the preoperative baseline to 18 months after the intervention. The number of medications decreased significantly by 89%. At 18 months postoperative, 79% eyes did not require any glaucoma medications. The incidence of complications after canaloplasty was low, and none of the adverse effects were vision threatening. A surgically-induced astigmatism was the most frequent complication. Pigmentary glaucoma patients were the most beneficial subgroup, with 50% reduction in IOP, the highest success rate, and 98% reduction in the number of medications used.
This study proved that canaloplasty is an efficient and safe procedure in OAG eyes.</description><identifier>ISSN: 0882-0538</identifier><identifier>EISSN: 1744-5205</identifier><identifier>DOI: 10.1080/08820538.2022.2034897</identifier><identifier>PMID: 35125052</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Canaloplasty ; Non-penetrating glaucoma surgery ; Open-angle glaucoma ; Schlemm's canal surgery</subject><ispartof>Seminars in ophthalmology, 2022-07, Vol.37 (5), p.602-610</ispartof><rights>2022 Taylor & Francis 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-b70b13c6014373c4092d3164827a3546d95b83dbc0113b7db90b6788d8a482653</citedby><cites>FETCH-LOGICAL-c366t-b70b13c6014373c4092d3164827a3546d95b83dbc0113b7db90b6788d8a482653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35125052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Łazicka - Gałecka, Monika</creatorcontrib><creatorcontrib>Kamińska, Anna</creatorcontrib><creatorcontrib>Gałecki, Tomasz</creatorcontrib><creatorcontrib>Guszkowska, Maria</creatorcontrib><creatorcontrib>Dziedziak, Jacek</creatorcontrib><creatorcontrib>Szaflik, Jerzy</creatorcontrib><creatorcontrib>Szaflik, Jacek P.</creatorcontrib><title>Canaloplasty - Efficacy and Safety in an 18-Month Follow Up Period, and Analysis of Outcomes in Primary Open Angle Glaucoma Pigmentary Glaucoma and Pseudoexfoliative Glaucoma</title><title>Seminars in ophthalmology</title><addtitle>Semin Ophthalmol</addtitle><description>Open-angle glaucoma (OAG), accounting for 90% of all glaucoma cases, is a progressive optic nerve neuropathy. It may lead to irreversible loss of visual field and complete blindness. When conservative treatment becomes insufficient to stop OAG progression, a surgical intervention is considered. Currently, canaloplasty procedure is being introduced instead of conventional trabeculectomy for invasive OAG treatment. The aim of the study is to asses safety and efficacy of canaloplasty.
This prospective study included 67 eyes that received 360° canaloplasty with placement of a tensioning suture. Primary OAG (n = 35), secondary OAG in pseudoexfoliative syndrome (n = 13), and pigmentary glaucoma (n = 19) patients were included. Control check-ups were conducted pre-operatively and in a 18-month follow-up time. Study endpoints involved reduction in IOP values and in the number of glaucoma medications after the intervention.
The intervention led to a significant 38% reduction in IOP value from the preoperative baseline to 18 months after the intervention. The number of medications decreased significantly by 89%. At 18 months postoperative, 79% eyes did not require any glaucoma medications. The incidence of complications after canaloplasty was low, and none of the adverse effects were vision threatening. A surgically-induced astigmatism was the most frequent complication. Pigmentary glaucoma patients were the most beneficial subgroup, with 50% reduction in IOP, the highest success rate, and 98% reduction in the number of medications used.
This study proved that canaloplasty is an efficient and safe procedure in OAG eyes.</description><subject>Canaloplasty</subject><subject>Non-penetrating glaucoma surgery</subject><subject>Open-angle glaucoma</subject><subject>Schlemm's canal surgery</subject><issn>0882-0538</issn><issn>1744-5205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EokPhEUBesiDFP0ns2VGN2lKpaEZqu7Yc_xQjxw520pKX4hlxOtN2hyzZuvd-51xZB4CPGJ1gxNFXxDlBDeUnBBFSLlrzNXsFVpjVddWU0WuwWphqgY7Au5x_IUQwI_QtOKINJg1qyAr83cggfRy8zOMMK3hmrVNSzVAGDa-lNaXrQqkg5tWPGMaf8Dx6Hx_g7QB3Jrmovzyyp8Vmzi7DaOF2GlXsTV6Uu-R6mWa4HUwo0J038MLLqcwl3Lm73oRxGT_3Fq9dNpOO5o-N3snR3b9I3oM3VvpsPhzeY3B7fnaz-V5dbS8uN6dXlaJtO1YdQx2mqkW4poyqGq2JpritOWGSNnWr103Hqe4Uwph2THdr1LWMc81lYdqGHoPPe98hxd-TyaPoXVbGexlMnLIgbTmEtY9os0dVijknY8Ww_7LASCxRiaeoxBKVOERVdJ8OK6auN_pZ9ZRNAb7tARdsTL18iMlrMcrZx2STDMplQf-_4x8deqLc</recordid><startdate>20220704</startdate><enddate>20220704</enddate><creator>Łazicka - Gałecka, Monika</creator><creator>Kamińska, Anna</creator><creator>Gałecki, Tomasz</creator><creator>Guszkowska, Maria</creator><creator>Dziedziak, Jacek</creator><creator>Szaflik, Jerzy</creator><creator>Szaflik, Jacek P.</creator><general>Taylor & Francis</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220704</creationdate><title>Canaloplasty - Efficacy and Safety in an 18-Month Follow Up Period, and Analysis of Outcomes in Primary Open Angle Glaucoma Pigmentary Glaucoma and Pseudoexfoliative Glaucoma</title><author>Łazicka - Gałecka, Monika ; Kamińska, Anna ; Gałecki, Tomasz ; Guszkowska, Maria ; Dziedziak, Jacek ; Szaflik, Jerzy ; Szaflik, Jacek P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-b70b13c6014373c4092d3164827a3546d95b83dbc0113b7db90b6788d8a482653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Canaloplasty</topic><topic>Non-penetrating glaucoma surgery</topic><topic>Open-angle glaucoma</topic><topic>Schlemm's canal surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Łazicka - Gałecka, Monika</creatorcontrib><creatorcontrib>Kamińska, Anna</creatorcontrib><creatorcontrib>Gałecki, Tomasz</creatorcontrib><creatorcontrib>Guszkowska, Maria</creatorcontrib><creatorcontrib>Dziedziak, Jacek</creatorcontrib><creatorcontrib>Szaflik, Jerzy</creatorcontrib><creatorcontrib>Szaflik, Jacek P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Łazicka - Gałecka, Monika</au><au>Kamińska, Anna</au><au>Gałecki, Tomasz</au><au>Guszkowska, Maria</au><au>Dziedziak, Jacek</au><au>Szaflik, Jerzy</au><au>Szaflik, Jacek P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Canaloplasty - Efficacy and Safety in an 18-Month Follow Up Period, and Analysis of Outcomes in Primary Open Angle Glaucoma Pigmentary Glaucoma and Pseudoexfoliative Glaucoma</atitle><jtitle>Seminars in ophthalmology</jtitle><addtitle>Semin Ophthalmol</addtitle><date>2022-07-04</date><risdate>2022</risdate><volume>37</volume><issue>5</issue><spage>602</spage><epage>610</epage><pages>602-610</pages><issn>0882-0538</issn><eissn>1744-5205</eissn><abstract>Open-angle glaucoma (OAG), accounting for 90% of all glaucoma cases, is a progressive optic nerve neuropathy. It may lead to irreversible loss of visual field and complete blindness. When conservative treatment becomes insufficient to stop OAG progression, a surgical intervention is considered. Currently, canaloplasty procedure is being introduced instead of conventional trabeculectomy for invasive OAG treatment. The aim of the study is to asses safety and efficacy of canaloplasty.
This prospective study included 67 eyes that received 360° canaloplasty with placement of a tensioning suture. Primary OAG (n = 35), secondary OAG in pseudoexfoliative syndrome (n = 13), and pigmentary glaucoma (n = 19) patients were included. Control check-ups were conducted pre-operatively and in a 18-month follow-up time. Study endpoints involved reduction in IOP values and in the number of glaucoma medications after the intervention.
The intervention led to a significant 38% reduction in IOP value from the preoperative baseline to 18 months after the intervention. The number of medications decreased significantly by 89%. At 18 months postoperative, 79% eyes did not require any glaucoma medications. The incidence of complications after canaloplasty was low, and none of the adverse effects were vision threatening. A surgically-induced astigmatism was the most frequent complication. Pigmentary glaucoma patients were the most beneficial subgroup, with 50% reduction in IOP, the highest success rate, and 98% reduction in the number of medications used.
This study proved that canaloplasty is an efficient and safe procedure in OAG eyes.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>35125052</pmid><doi>10.1080/08820538.2022.2034897</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0882-0538 |
ispartof | Seminars in ophthalmology, 2022-07, Vol.37 (5), p.602-610 |
issn | 0882-0538 1744-5205 |
language | eng |
recordid | cdi_proquest_miscellaneous_2626227665 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Canaloplasty Non-penetrating glaucoma surgery Open-angle glaucoma Schlemm's canal surgery |
title | Canaloplasty - Efficacy and Safety in an 18-Month Follow Up Period, and Analysis of Outcomes in Primary Open Angle Glaucoma Pigmentary Glaucoma and Pseudoexfoliative Glaucoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T13%3A29%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Canaloplasty%20-%20Efficacy%20and%20Safety%20in%20an%2018-Month%20Follow%20Up%20Period,%20and%20Analysis%20of%20Outcomes%20in%20Primary%20Open%20Angle%20Glaucoma%20Pigmentary%20Glaucoma%20and%20Pseudoexfoliative%20Glaucoma&rft.jtitle=Seminars%20in%20ophthalmology&rft.au=%C5%81azicka%20-%20Ga%C5%82ecka,%20Monika&rft.date=2022-07-04&rft.volume=37&rft.issue=5&rft.spage=602&rft.epage=610&rft.pages=602-610&rft.issn=0882-0538&rft.eissn=1744-5205&rft_id=info:doi/10.1080/08820538.2022.2034897&rft_dat=%3Cproquest_pubme%3E2626227665%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-b70b13c6014373c4092d3164827a3546d95b83dbc0113b7db90b6788d8a482653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2626227665&rft_id=info:pmid/35125052&rfr_iscdi=true |